These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
47. Sex-related differences in plasminogen activator and plasminogen activator inhibiting activities in young and aged rats. Kojima T; Doi K; Kish M; Horiguchi Y Res Commun Mol Pathol Pharmacol; 1999; 104(1):81-91. PubMed ID: 10604281 [TBL] [Abstract][Full Text] [Related]
48. [Sodium tanshinone IIA sulfonate prevents postoperative peritoneal adhesions in rats by enhancing the activity of the peritoneal fibrinolytic system]. Lin S; Qin F; Song LY; Hou CQ; Hou LB Nan Fang Yi Ke Da Xue Xue Bao; 2016 Feb; 36(2):260-4. PubMed ID: 26922027 [TBL] [Abstract][Full Text] [Related]
49. Effects of saline lavage temperature on peritoneal fibrinolysis and adhesion formation. Koca YS; Tarhan ÖR; Kaya S; Gökçe Ceylan B Ulus Travma Acil Cerrahi Derg; 2016 Jan; 22(1):1-6. PubMed ID: 27135070 [TBL] [Abstract][Full Text] [Related]
50. Effect of experimental peritonitis and ischaemia on peritoneal fibrinolytic activity. Vipond MN; Whawell SA; Thompson JN; Dudley HA Eur J Surg; 1994 Sep; 160(9):471-7. PubMed ID: 7849165 [TBL] [Abstract][Full Text] [Related]
51. Transforming growth factor beta inhibits plasminogen activator (PA) activity and stimulates production of urokinase-type PA, PA inhibitor-1 mRNA, and protein in rat osteoblast-like cells. Allan EH; Zeheb R; Gelehrter TD; Heaton JH; Fukumoto S; Yee JA; Martin TJ J Cell Physiol; 1991 Oct; 149(1):34-43. PubMed ID: 1834680 [TBL] [Abstract][Full Text] [Related]
52. Gonadotropin-releasing hormone agonist (GnRH-a) therapy alters activity of plasminogen activators, matrix metalloproteinases, and their inhibitors in rat models for adhesion formation and endometriosis: potential GnRH-a-regulated mechanisms reducing adhesion formation. Sharpe-Timms KL; Zimmer RL; Jolliff WJ; Wright JA; Nothnick WB; Curry TE Fertil Steril; 1998 May; 69(5):916-23. PubMed ID: 9591503 [TBL] [Abstract][Full Text] [Related]
53. Tissue-specific and time-coordinated hormone regulation of plasminogen-activator-inhibitor type I and tissue-type plasminogen activator in the rat ovary during gonadotropin-induced ovulation. Liu YX; Peng XR; Ny T Eur J Biochem; 1991 Jan; 195(2):549-55. PubMed ID: 1900052 [TBL] [Abstract][Full Text] [Related]
54. Expression of urokinase-type plasminogen activator and its receptor during ovarian follicular development. Li M; Karakji EG; Xing R; Fryer JN; Carnegie JA; Rabbani SA; Tsang BK Endocrinology; 1997 Jul; 138(7):2790-9. PubMed ID: 9202219 [TBL] [Abstract][Full Text] [Related]
55. Effect of recombinant tissue plasminogen activator on intra-abdominal abscess formation in rats with generalized peritonitis. van Goor H; de Graaf JS; Kooi K; Sluiter WJ; Bom VJ; van der Meer J; Bleichrodt RP J Am Coll Surg; 1994 Oct; 179(4):407-11. PubMed ID: 7921389 [TBL] [Abstract][Full Text] [Related]
56. Long-term analysis of peritoneal plasminogen activator activity and adhesion formation after surgical trauma in the rat model. Bakkum EA; Emeis JJ; Dalmeijer RA; van Blitterswijk CA; Trimbos JB; Trimbos-Kemper TC Fertil Steril; 1996 Dec; 66(6):1018-22. PubMed ID: 8941072 [TBL] [Abstract][Full Text] [Related]
57. The mechanism of the reaction between human plasminogen-activator inhibitor 1 and tissue plasminogen activator. Lindahl TL; Ohlsson PI; Wiman B Biochem J; 1990 Jan; 265(1):109-13. PubMed ID: 2105714 [TBL] [Abstract][Full Text] [Related]
58. Progestin inhibits and thrombin stimulates the plasminogen activator/inhibitor system in term decidual stromal cells: implications for parturition. Norwitz ER; Snegovskikh V; Schatz F; Foyouzi N; Rahman M; Buchwalder L; Lee HJ; Funai EF; Buhimschi CS; Buhimschi IA; Lockwood CJ Am J Obstet Gynecol; 2007 Apr; 196(4):382.e1-8. PubMed ID: 17403427 [TBL] [Abstract][Full Text] [Related]
59. A Time Course of Bevacizumab (Anti-VEGF) Effect on Rat Peritoneum: Relations Between Antiadhesive Action and Fibrin Regulation Enzymes. Micha AE; Psarras K; Ouroumidis O; Siska E; Vlachaki E; Lymperopoulos A; Symeonidis N; Nikolaidou C; Venizelos I; Koliakos G; Pavlidis TE Surg Innov; 2017 Dec; 24(6):543-551. PubMed ID: 28877644 [TBL] [Abstract][Full Text] [Related]
60. TM5275 prolongs secreted tissue plasminogen activator retention and enhances fibrinolysis on vascular endothelial cells. Yasui H; Suzuki Y; Sano H; Suda T; Chida K; Dan T; Miyata T; Urano T Thromb Res; 2013 Jul; 132(1):100-5. PubMed ID: 23611258 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]